hg_110432.1

Basic information about the TSS

---

TSS ID: hg_110432.1 Species: human Chr: chr10		Start: 87094908 End: 87094942 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: AK297456 Distance: 10 GeneID: 2746 HGNC/MGI_ID: HGNC:4335 UniProt_ID: B4DMG8

Gene_name: glutamate dehydrogenase 1 Gene_symbol: GLUD1 Gene_synonyms: GDH Gene_source: HGNC:4335

TATA-Box annotation

---

Distance to TSS:	-82
Nearest PromoterID:	NM_005271
Entrez ID:	2746
Nearest Unigene:	Hs.500409
Nearest Refseq:	NM_005271
Nearest Ensembl:	ENSG00000148672
Gene Name:	glutamate dehydrogenase 1
Gene Alias:	GDH|GDH1|GLUD
Gene Description:	glutamate dehydrogenase 1
Gene Type:	protein-coding
CpG%:	0.14
GC%:	0.771144
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):	49(CGGCTTAAAAGG,-,0.00),51(GCTTAAAAGGGC,+,0.00)

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@GLUD1 p3@GLUD1 p4@GLUD1 p5@GLUD1
Sample		p1@GLUD1	p3@GLUD1	p4@GLUD1	p5@GLUD1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	12.86	2.14	0.78	1.75
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	11.33	3.03	0.61	1.62
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	13.89	2.51	1.54	1.74
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	16.42	1.04	1.66	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	13.72	1.80	0.67	1.12
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	9.88	1.16	1.36	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	16.34	2.18	1.96	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	13.32	1.70	0.48	1.21
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	20.73	2.35	0.85	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	12.17	4.64	2.90	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	11.32	1.21	0.40	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	10.57	1.63	1.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	12.41	2.42	1.29	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	6.92	1.65	1.50	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	7.90	0.88	1.54	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	10.06	2.01	0.25	1.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	8.74	2.18	0.44	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	8.44	2.11	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	8.53	1.07	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	8.12	1.65	1.65	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	8.42	1.47	1.87	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	9.84	3.45	3.28	0.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	7.63	1.55	0.65	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	10.19	2.18	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	14.96	2.06	1.55	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	9.18	1.27	1.90	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	6.04	3.30	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	8.72	3.30	0.71	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	8.56	2.26	1.29	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	10.32	2.90	2.53	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	9.00	2.93	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	8.40	2.34	1.17	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	9.29	1.90	0.84	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	5.94	2.14	0.82	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	8.04	1.87	1.12	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	9.96	2.30	0.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	9.61	1.84	2.25	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	11.28	1.21	0.60	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	7.83	1.08	1.08	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	8.16	1.68	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	8.47	1.88	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	5.42	1.02	0.73	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	8.01	1.69	1.69	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	5.94	2.27	0.87	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	12.45	2.61	0.80	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	7.91	1.63	1.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	7.20	1.20	1.44	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	8.94	1.49	2.09	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	9.81	2.39	1.44	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	7.08	2.02	1.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	5.74	2.66	1.84	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	8.23	2.22	0.67	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	8.87	1.06	1.06	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	5.63	1.33	1.66	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	1.68	1.68	3.36	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	3.67	0.46	0.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	10.37	1.30	2.27	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	8.03	2.89	1.61	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	5.03	0.94	1.57	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	4.23	1.41	0.71	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	5.61	2.24	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	6.37	0.00	1.59	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	2.72	2.04	2.38	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	10.40	2.60	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	12.07	5.32	2.13	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	7.90	0.00	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	9.75	0.49	2.44	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	10.91	0.99	0.00	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	10.79	1.41	2.81	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	10.27	3.97	1.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	11.75	2.17	1.86	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	12.23	1.83	1.83	1.53
Adipocyte - breast, donor1	11376-118A8	14.10	2.38	3.80	3.48
Adipocyte - breast, donor2	11327-117E4	16.20	2.09	4.01	2.41
Adipocyte - omental, donor1	11473-119C6	14.25	3.82	3.31	3.18
Adipocyte - omental, donor2	11474-119C7	5.23	1.49	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	11.39	4.02	1.00	1.34
Adipocyte - perirenal, donor1	11476-119C9	8.29	3.19	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	9.90	2.20	3.30	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	18.97	0.90	1.35	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	14.77	5.91	3.13	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	17.01	2.54	1.96	1.17
Adipocyte differentiation, day04, donor2	13022-139D7	8.49	1.29	0.51	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	17.28	2.79	1.67	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	21.16	2.94	2.94	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	19.30	3.86	3.30	0.88
Adipocyte differentiation, day08, donor2	13023-139D8	10.65	1.61	1.61	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	10.13	2.13	4.27	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	10.57	1.11	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	22.46	2.50	2.50	2.08
Adipocyte differentiation, day12, donor2	13024-139D9	12.56	3.27	2.51	1.00
Adipocyte differentiation, day12, donor3	13027-139E3	11.45	1.64	0.65	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	12.48	1.83	0.91	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	5.97	1.77	1.33	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	1.79	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	12.41	1.08	2.52	0.72
Amniotic Epithelial Cells, donor2	11613-122A2	3.35	3.35	3.35	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	6.78	1.23	2.67	0.62
Anulus Pulposus Cell, donor1	11248-116E6	18.88	1.72	4.81	2.06
Anulus Pulposus Cell, donor2	11463-119B5	11.02	2.69	1.96	1.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	4.49	0.90	1.35	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	7.81	3.04	1.30	3.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	8.56	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	8.07	3.29	2.69	2.69
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	7.59	1.26	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	7.92	0.00	2.64	2.64
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	6.17	2.60	1.95	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	10.19	1.46	1.94	2.43
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	4.75	1.19	1.78	3.56
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	9.42	2.26	1.88	4.14
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	7.98	1.45	0.73	2.90
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	5.02	1.25	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	7.91	1.65	2.14	0.99
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	4.09	1.36	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	11.76	2.26	2.87	3.02
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	10.72	3.21	0.54	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	6.99	0.94	1.32	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	8.55	1.87	1.60	2.14
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	13.66	2.93	0.98	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	7.46	2.65	0.83	1.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	12.01	0.00	2.40	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	10.62	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	6.35	3.09	2.40	2.23
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	6.80	4.37	0.49	4.85
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	9.49	3.04	0.76	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	12.11	1.21	1.21	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	7.41	2.85	2.28	5.13
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	9.41	1.92	0.86	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	8.78	2.06	1.55	4.13
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	7.04	4.69	1.41	4.69
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	6.75	5.14	1.61	1.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	8.56	2.14	0.71	2.85
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	5.26	4.68	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	8.73	1.20	0.90	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	4.75	0.00	2.38	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	6.61	3.56	0.51	2.03
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	10.19	2.55	1.02	4.33
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	10.80	1.27	1.27	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	14.24	0.43	0.43	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	9.10	2.12	0.42	2.96
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	6.67	1.16	1.45	2.03
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	10.39	1.89	0.00	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	8.48	3.22	1.19	2.88
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	6.95	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	5.57	2.14	0.86	1.50
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	6.62	1.20	1.20	5.41
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	3.64	0.73	0.73	2.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	5.98	2.99	0.92	1.38
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	9.41	2.54	2.54	2.29
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	7.02	3.30	1.65	2.48
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	7.96	0.92	2.14	3.37
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	8.60	3.35	0.00	3.35
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	6.87	3.33	1.11	2.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	6.65	1.66	2.77	2.22
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	6.09	3.18	0.53	2.38
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	7.27	0.73	1.45	1.45
Astrocyte - cerebellum, donor1	11500-119F6	9.46	2.82	0.61	0.86
Astrocyte - cerebellum, donor2	11580-120F5	9.58	2.57	1.20	0.51
Astrocyte - cerebellum, donor3	11661-122F5	3.57	2.31	0.42	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	18.82	2.44	1.39	2.44
Astrocyte - cerebral cortex, donor2	11316-117D2	33.00	4.37	3.56	1.46
Astrocyte - cerebral cortex, donor3	11392-118C6	34.01	4.03	3.58	1.64
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	34.29	3.90	3.90	1.26
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	31.07	3.26	4.38	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	34.48	3.41	3.41	1.59
Basophils, donor1	12241-129G9	13.34	2.88	2.88	0.26
Basophils, donor2	12242-129H1	20.20	3.25	5.77	0.36
Basophils, donor3	12243-129H2	28.66	5.14	6.17	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	5.17	1.72	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	1.83	0.46	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	11.30	1.88	0.63	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	9.77	1.87	0.42	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	14.51	0.92	1.15	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	19.25	3.06	1.62	3.42
Burkitt's lymphoma cell line:DAUDI	10422-106C8	28.24	1.13	2.27	1.96
Burkitt's lymphoma cell line:RAJI	10476-106I8	48.68	1.86	2.10	3.49
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	29.74	4.16	4.16	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	10.34	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	14.09	2.82	5.07	0.56
CD14+ Monocytes, donor2	11305-117B9	12.06	2.04	2.78	2.78
CD14+ Monocytes, donor3	11381-118B4	20.42	2.41	6.15	1.76
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	20.66	6.23	9.06	1.70
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	18.95	3.03	7.58	2.27
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	26.63	4.27	5.59	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	18.36	2.17	4.63	3.61
CD14+ monocytes - mock treated, donor2	11873-125C1	14.48	2.11	1.81	1.21
CD14+ monocytes - mock treated, donor3	11883-125D2	17.53	3.32	3.08	1.66
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	12.05	1.51	2.68	2.01
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	5.52	0.55	1.66	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	10.17	0.50	2.98	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	10.38	1.57	2.74	1.57
CD14+ monocytes - treated with BCG, donor2	11870-125B7	11.57	0.89	2.14	0.89
CD14+ monocytes - treated with BCG, donor3	11880-125C8	12.19	1.96	1.52	1.52
CD14+ monocytes - treated with Candida, donor1	11868-125B5	15.69	0.94	2.81	1.64
CD14+ monocytes - treated with Candida, donor2	11878-125C6	6.86	2.11	1.58	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	13.31	2.22	4.44	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	18.74	1.04	4.02	2.38
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	8.98	1.20	1.40	1.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	12.08	1.46	2.50	1.46
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	15.10	2.06	5.03	2.29
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	9.05	1.58	1.81	0.90
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	7.86	1.31	2.18	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	9.15	1.08	3.23	1.34
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	13.96	1.74	3.84	1.74
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	14.73	2.10	2.10	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	8.82	1.29	2.57	1.47
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	5.99	0.70	3.87	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	7.90	0.00	3.51	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	13.95	1.92	2.27	2.79
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	11.15	0.74	2.60	1.49
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	14.01	2.59	1.29	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	11.06	1.23	1.23	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	5.56	0.23	0.70	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	10.21	0.93	2.55	1.86
CD14+CD16+ Monocytes, donor1	11789-124B7	15.69	3.71	2.83	1.31
CD14+CD16+ Monocytes, donor2	11801-124D1	15.01	3.70	3.00	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	15.60	2.38	3.47	1.08
CD14+CD16- Monocytes, donor1	11788-124B6	20.71	2.18	11.83	2.34
CD14+CD16- Monocytes, donor2	11799-124C8	17.29	2.10	5.94	1.40
CD14+CD16- Monocytes, donor3	11910-125G2	13.82	1.56	2.90	1.11
CD14-CD16+ Monocytes, donor1	11790-124B8	16.59	4.34	7.66	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	16.69	5.93	7.25	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	12.21	4.00	6.32	1.68
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	6.10	4.06	4.06	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	23.05	4.75	6.10	2.71
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	17.61	3.11	2.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	23.45	1.07	5.86	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	21.44	1.07	4.29	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	17.55	1.40	2.81	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	14.90	0.78	3.14	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	18.46	1.32	6.59	2.64
CD19+ B Cells, donor1	11544-120B5	27.94	3.29	3.29	0.82
CD19+ B Cells, donor2	11624-122B4	26.84	2.18	1.45	1.45
CD19+ B Cells, donor3	11705-123B4	17.67	1.01	2.02	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	2.02	1.21	2.83	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	3.99	1.60	1.20	0.40
CD34+ Progenitors, donor1	11545-120B6	11.04	2.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	10.67	1.12	0.00	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	26.68	1.88	2.25	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	25.03	2.25	4.28	1.35
CD4+ T Cells, donor1	11225-116C1	16.07	3.21	3.21	1.79
CD4+ T Cells, donor2	11306-117C1	14.08	3.06	3.06	5.51
CD4+ T Cells, donor3	11382-118B5	25.31	3.05	2.74	2.13
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	20.93	1.28	2.81	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	24.71	2.47	5.17	4.27
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	18.97	1.44	3.45	1.72
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	11.85	2.84	2.37	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	15.45	2.81	2.11	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	6.59	6.59	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	20.09	2.89	4.19	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	24.57	3.56	3.56	3.22
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	23.05	3.06	1.93	4.03
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	29.14	4.03	1.79	3.59
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	26.20	3.49	2.10	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	23.76	3.08	2.20	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	19.40	1.69	1.69	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	23.27	1.45	2.91	4.36
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	24.06	1.34	1.67	3.01
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	11.97	2.99	3.26	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	11.25	5.36	0.54	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	8.97	3.59	3.59	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	27.81	2.60	2.04	1.48
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	29.89	2.38	5.20	2.82
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	28.16	5.25	4.83	1.89
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	21.74	8.60	4.55	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	13.43	4.77	3.47	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	16.56	3.92	1.74	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	22.76	8.41	2.97	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	19.39	0.00	3.69	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	23.73	4.19	4.19	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	16.34	4.71	1.11	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	18.90	8.83	1.72	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	18.48	10.78	6.16	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	21.85	5.01	5.01	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	13.85	9.69	1.38	1.38
CD8+ T Cells, donor1	11226-116C2	17.35	2.95	2.95	1.96
CD8+ T Cells, donor2	11307-117C2	22.15	3.00	1.88	3.00
CD8+ T Cells, donor3	11383-118B6	22.72	6.56	2.27	2.78
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	16.75	0.92	0.23	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	16.54	0.48	0.48	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	19.70	0.27	0.82	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	11.71	0.60	0.60	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	18.00	2.16	0.24	1.44
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	16.83	1.14	0.45	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	17.17	0.65	0.43	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	16.58	0.00	0.79	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	14.77	0.70	1.64	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	11.77	0.30	0.91	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	16.27	0.29	0.29	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	15.72	1.07	1.60	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	17.51	0.88	0.00	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	10.02	0.46	0.00	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	9.70	0.00	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	15.85	0.36	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	16.98	0.86	0.58	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	15.08	0.24	0.00	1.18
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	17.11	1.58	1.58	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	19.07	0.31	0.62	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	12.50	1.60	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	16.06	0.00	1.53	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	12.61	0.79	0.39	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	9.83	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	11.24	0.80	1.61	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	16.09	2.10	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	17.03	2.00	2.00	1.00
Cardiac Myocyte, donor1	11525-119I4	10.97	1.83	3.66	0.00
Cardiac Myocyte, donor2	11605-120I3	14.33	1.98	1.48	0.49
Cardiac Myocyte, donor3	11686-122I3	18.94	5.05	3.26	0.32
Chondrocyte - de diff, donor1	11261-116G1	20.80	4.16	0.69	5.55
Chondrocyte - de diff, donor2	11338-117F6	8.17	4.62	1.42	0.36
Chondrocyte - de diff, donor3	11410-118E6	16.95	2.96	5.12	2.84
Chondrocyte - re diff, donor2	11339-117F7	11.64	7.16	0.90	0.90
Chondrocyte - re diff, donor3	11411-118E7	8.49	4.45	2.43	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	25.94	3.90	4.36	2.98
Ciliary Epithelial Cells, donor2	11323-117D9	21.59	3.21	2.57	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	20.00	4.16	2.30	0.53
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	33.29	2.84	2.75	1.47
Corneal Epithelial Cells, donor1	11526-119I5	3.95	1.32	0.66	0.00
Corneal Epithelial Cells, donor2	11606-120I4	2.28	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	8.44	0.77	1.02	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	26.91	2.31	7.10	1.16
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	20.82	2.52	9.78	3.15
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	3.45	6.90	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	21.17	3.02	4.86	1.84
Dendritic Cells - plasmacytoid, donor1	11228-116C4	11.27	3.76	3.07	2.73
Dendritic Cells - plasmacytoid, donor2	11309-117C4	9.79	5.88	5.22	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	9.68	3.87	0.97	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	16.34	1.83	2.00	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	11.15	0.59	2.35	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	9.33	2.55	1.13	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	9.04	1.18	0.79	0.00
Endothelial Cells - Artery, donor1	11264-116G4	12.22	2.04	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	16.47	1.18	2.12	0.94
Endothelial Cells - Artery, donor3	11413-118E9	17.53	1.93	0.88	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	14.19	1.99	1.55	1.99
Endothelial Cells - Lymphatic, donor2	11317-117D3	11.26	2.13	2.43	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	11.28	3.66	1.69	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	6.83	3.57	0.89	1.78
Endothelial Cells - Microvascular, donor2	11342-117G1	6.77	1.04	0.00	1.56
Endothelial Cells - Microvascular, donor3	11414-118F1	10.63	1.84	1.42	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	12.80	2.40	0.40	2.80
Endothelial Cells - Thoracic, donor2	11343-117G2	8.91	3.14	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	24.85	2.36	2.98	1.74
Endothelial Cells - Umbilical vein, donor2	11324-117E1	16.73	0.87	1.09	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	15.14	1.95	1.10	0.12
Endothelial Cells - Vein, donor1	11267-116G7	9.10	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	11.87	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	17.58	1.73	1.57	0.31
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	8.25	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	3.91	1.47	0.98	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	11.49	2.05	2.46	2.46
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	7.55	2.19	0.99	0.88
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	13.54	3.68	2.49	0.87
Fibroblast - Aortic Adventitial, donor1	11245-116E3	18.07	2.30	2.91	1.94
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	19.79	6.69	4.09	1.23
Fibroblast - Aortic Adventitial, donor2	11326-117E3	12.23	2.74	2.11	1.27
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	11.86	1.32	0.26	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	24.58	4.32	2.33	1.33
Fibroblast - Cardiac, donor1	11268-116G8	15.42	3.18	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	7.58	0.76	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	8.36	1.73	1.10	0.16
Fibroblast - Cardiac, donor4	11452-119A3	23.64	4.24	4.85	0.00
Fibroblast - Cardiac, donor5	11456-119A7	23.60	5.20	1.02	0.76
Fibroblast - Cardiac, donor6	11460-119B2	17.58	4.24	1.67	1.06
Fibroblast - Choroid Plexus, donor1	11492-119E7	10.18	4.69	0.40	1.21
Fibroblast - Choroid Plexus, donor2	11572-120E6	20.28	2.59	2.16	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	13.18	5.86	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	12.45	2.77	0.92	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	26.80	5.26	6.95	1.02
Fibroblast - Dermal, donor1	11269-116G9	20.43	8.22	3.52	0.94
Fibroblast - Dermal, donor2	11346-117G5	13.21	2.36	1.42	1.89
Fibroblast - Dermal, donor3	11418-118F5	31.55	7.74	6.77	4.35
Fibroblast - Dermal, donor4	11450-119A1	29.17	3.96	1.58	1.36
Fibroblast - Dermal, donor5	11454-119A5	32.27	2.62	1.57	1.22
Fibroblast - Dermal, donor6	11458-119A9	29.89	3.90	1.79	1.62
Fibroblast - Gingival, donor1	11237-116D4	29.57	3.54	5.41	2.71
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	28.82	3.14	3.93	1.05
Fibroblast - Gingival, donor2	11318-117D4	31.50	2.77	3.82	2.50
Fibroblast - Gingival, donor3	11394-118C8	31.52	3.87	3.87	0.58
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	22.86	1.04	2.08	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	14.10	4.05	3.52	1.59
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	26.81	2.96	3.27	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	18.12	3.65	1.89	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	7.76	2.47	2.12	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	15.79	1.90	3.51	1.02
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	15.82	1.91	2.18	1.36
Fibroblast - Gingival, donor8 (control)	11926-125H9	18.21	2.30	1.86	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	15.55	4.26	3.96	0.73
Fibroblast - Lung, donor1	11270-116H1	23.11	1.36	4.08	0.00
Fibroblast - Lung, donor2	11347-117G6	32.83	4.48	4.48	2.98
Fibroblast - Lung, donor3	11419-118F6	36.51	6.75	3.59	1.90
Fibroblast - Lymphatic, donor1	11506-119G3	5.00	1.67	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	6.99	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	2.80	0.56	0.56	0.28
Fibroblast - Mammary, donor1	11540-120B1	14.61	2.03	2.03	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	27.54	3.30	4.27	2.91
Fibroblast - Periodontal Ligament, donor2	11319-117D5	43.68	3.34	3.03	1.37
Fibroblast - Periodontal Ligament, donor3	11395-118C9	36.72	5.51	6.43	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	17.17	4.20	4.58	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	14.04	4.05	3.24	2.16
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	13.92	2.78	2.09	0.81
Fibroblast - Pulmonary Artery, donor1	11250-116E8	16.91	3.54	3.54	2.10
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	9.96	2.03	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	8.02	2.00	2.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	24.12	5.93	3.95	1.58
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	14.49	2.58	1.19	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	9.24	3.02	2.84	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	10.84	2.17	3.55	1.77
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	20.46	4.51	1.50	2.11
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	8.53	4.43	1.30	1.08
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	14.93	5.57	1.01	1.01
Fibroblast - skin normal, donor1	11553-120C5	7.88	3.77	2.30	1.64
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	29.47	3.61	5.41	2.21
Fibroblast - skin normal, donor2	11561-120D4	8.94	4.32	0.70	0.90
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	22.06	4.84	1.51	1.51
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	10.44	3.23	2.49	2.40
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	10.60	4.10	1.71	1.54
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	11.17	5.25	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	12.57	4.37	1.28	0.96
Fibroblast - skin walker warburg, donor1	11554-120C6	10.63	4.22	2.87	0.84
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	5.33	1.88	1.57	1.41
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	6.10	6.10	2.61	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	12.31	3.47	2.25	1.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	15.35	2.86	2.08	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	14.31	3.32	2.56	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	61.24	1.53	0.77	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	47.86	0.64	1.28	3.19
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	39.94	1.71	2.28	8.27
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	69.22	6.89	4.41	6.62
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	35.85	3.65	3.42	4.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	41.01	1.78	2.58	4.95
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	58.42	6.08	3.44	8.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	41.75	2.94	1.96	3.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	30.96	2.65	2.65	4.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	29.54	2.12	0.57	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	20.32	2.71	0.74	1.35
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	31.97	4.30	2.42	3.22
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	21.56	2.60	1.61	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	21.18	2.35	0.55	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	22.16	2.03	1.22	2.03
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	23.05	2.05	2.51	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	22.17	1.49	2.24	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	29.29	2.84	2.84	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	23.05	0.59	2.36	3.55
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	19.23	3.02	0.16	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	29.27	2.90	2.01	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	26.21	1.01	2.42	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	18.66	3.05	0.34	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	27.93	1.95	2.48	1.15
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	22.79	3.23	3.33	1.14
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	17.93	2.39	1.88	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	18.15	3.43	0.55	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	27.45	2.50	2.33	1.41
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	24.91	1.02	2.45	1.63
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	20.01	2.68	2.89	2.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	14.41	2.77	0.35	1.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	24.85	2.50	2.67	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	18.30	2.20	3.53	1.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	20.05	3.44	0.86	1.60
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	23.67	2.76	1.95	1.30
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	23.73	4.81	2.89	1.92
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	16.39	3.22	0.95	0.57
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	17.87	2.69	3.01	1.27
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	15.81	3.34	3.65	2.13
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	15.37	3.55	1.99	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	19.98	2.42	2.42	1.10
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	20.48	3.65	1.12	1.96
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	14.63	3.06	0.46	0.74
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	20.59	2.67	1.87	1.34
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	23.87	2.75	2.30	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	16.45	3.24	1.30	1.04
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	21.69	1.63	4.88	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	13.83	3.13	3.13	1.47
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	18.42	3.73	2.85	1.75
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	8.93	2.98	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	15.30	3.03	3.43	1.85
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	16.75	3.83	3.23	1.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	8.13	3.81	2.03	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	31.45	2.99	1.00	2.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	28.50	5.24	1.69	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	36.42	4.50	0.41	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	44.44	2.82	3.13	2.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	42.95	0.85	2.54	3.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	37.82	2.77	0.46	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	61.87	2.47	2.47	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	40.61	1.55	0.00	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	41.72	0.00	1.60	8.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	31.30	1.74	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	41.01	0.65	3.25	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	36.65	1.24	2.06	3.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	37.75	1.68	0.28	3.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	39.87	0.98	0.98	2.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	45.30	1.68	1.68	5.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	39.12	0.64	0.64	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	35.32	1.36	1.36	3.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	54.29	4.18	2.09	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	43.53	4.58	0.57	4.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	26.64	1.48	0.89	6.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	30.49	0.00	0.00	8.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	34.79	1.24	0.41	4.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	38.89	2.99	1.61	2.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	0.00	0.00	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	36.90	1.15	0.77	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	26.73	1.96	1.63	2.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	38.79	0.00	1.34	4.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	33.90	3.47	0.77	5.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	30.13	2.05	1.37	4.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	24.85	2.48	0.00	19.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	30.67	4.25	0.47	4.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	21.73	1.81	1.21	6.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	32.56	3.56	0.51	4.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	30.71	2.39	0.80	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	31.08	1.48	0.99	4.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	40.13	2.36	0.00	7.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	19.25	4.08	1.75	11.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	34.67	2.19	1.76	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	19.50	0.00	1.70	11.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	22.68	1.79	1.19	12.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	23.29	0.97	0.49	3.88
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	5.71	2.28	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	10.40	3.33	2.08	3.33
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	19.12	5.62	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	9.20	3.81	4.44	2.54
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	13.37	4.18	3.34	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	13.46	1.51	1.97	1.74
Hep-2 cells mock treated, biol_rep2	11899-125E9	13.50	1.35	1.52	1.86
Hep-2 cells mock treated, biol_rep3	11900-125F1	12.06	1.37	1.37	1.59
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	15.30	1.53	1.09	1.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	15.26	2.15	1.07	1.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	10.98	1.08	0.65	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	17.31	1.49	0.37	2.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	14.07	1.54	0.86	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	9.61	0.64	0.00	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	10.07	2.24	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	4.33	0.87	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	7.05	0.35	1.06	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	4.36	0.00	2.18	2.18
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	17.48	3.15	1.22	2.62
Hepatocyte, donor1	11523-119I2	125.90	0.00	0.00	15.74
Hepatocyte, donor2	11603-120I1	120.66	1.08	0.00	15.08
Hepatocyte, donor3	11684-122I1	169.95	1.84	3.68	12.27
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	22.19	1.96	0.65	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	98.75	1.22	2.62	11.71
Iris Pigment Epithelial Cells, donor1	11530-119I9	16.19	1.65	2.20	1.10
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	9.55	0.00	9.55	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	12.46	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	15.38	5.13	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	19.49	4.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	8.34	1.67	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	10.89	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	2.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	16.63	1.11	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	17.01	0.00	2.52	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	12.37	0.00	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	9.04	1.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	12.88	3.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	15.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	10.50	2.52	2.52	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	12.06	3.21	1.61	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	12.00	2.77	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	13.22	0.47	0.94	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	8.16	3.63	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	15.07	2.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	11.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	10.84	0.64	1.28	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	9.11	0.00	3.65	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	12.85	0.71	2.14	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	10.19	1.85	1.23	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	5.27	3.51	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	9.04	4.87	1.39	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	15.49	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	19.45	6.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	4.36	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	11.25	0.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	0.00	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	9.60	1.07	2.13	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	16.63	0.00	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	12.89	0.92	1.84	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	7.40	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	8.08	1.39	2.61	1.96
Keratinocyte - epidermal, donor2	11349-117G8	8.20	2.93	1.17	0.00
Keratinocyte - epidermal, donor3	11421-118F8	13.82	2.46	1.61	1.51
Keratinocyte - oral, donor1	11251-116E9	26.90	3.52	4.65	3.86
Keratocytes, donor1	11527-119I6	8.94	2.06	0.00	0.34
Keratocytes, donor2	11607-120I5	5.86	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	22.53	1.38	3.75	2.37
Krukenberg tumor cell line:HSKTC	10687-109F3	6.59	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	14.02	1.08	2.16	3.24
Lens Epithelial Cells, donor2	11609-120I7	17.99	4.84	3.46	1.73
Lens Epithelial Cells, donor3	11690-122I7	12.21	3.43	1.41	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	10.20	2.25	2.49	1.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	8.37	0.56	2.79	1.67
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	12.91	1.57	2.52	2.36
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	6.99	0.54	0.00	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	10.72	0.32	1.89	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.87	0.75	1.40	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	9.44	0.82	3.28	2.05
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	8.60	1.26	0.76	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	9.01	0.70	0.70	1.69
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	9.10	1.58	1.58	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	12.02	2.33	1.74	1.55
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	6.11	1.48	0.74	1.67
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	11.85	1.39	2.44	1.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	9.30	0.95	1.67	1.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	7.14	1.10	1.37	0.96
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	10.47	0.92	1.54	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	7.79	0.62	0.94	1.25
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	8.97	0.73	1.28	1.83
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	9.87	1.65	0.00	1.97
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	6.15	0.29	1.46	1.17
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	8.46	0.50	1.00	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	8.24	2.42	1.94	2.91
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	13.73	1.35	1.62	2.42
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	9.84	1.67	1.36	1.36
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	5.18	0.52	1.56	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	10.47	2.09	1.47	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	11.88	1.65	1.50	1.65
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	12.38	1.38	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	13.36	0.94	2.45	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	9.33	0.42	1.70	0.53
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	11.15	1.94	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	11.58	0.99	2.32	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	7.06	0.99	1.61	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	10.37	2.22	0.74	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	12.11	0.99	2.47	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	8.39	1.10	1.10	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	13.51	1.61	1.93	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	9.74	1.52	1.52	2.13
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	11.34	1.68	1.40	0.84
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	8.53	2.13	2.13	1.78
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	10.67	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	7.47	0.47	2.02	0.78
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	10.03	1.79	2.86	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	13.07	1.31	1.96	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.00	1.65	1.18	1.18
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	11.01	1.86	2.48	1.11
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	9.22	0.26	1.28	1.28
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	5.37	0.00	0.60	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	2.27	4.53	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	3.84	2.30	1.53	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	5.20	0.74	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	7.19	0.85	2.12	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	7.74	2.11	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	3.74	0.93	2.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	4.64	0.52	1.55	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	5.95	4.76	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	6.11	3.17	1.36	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	9.31	1.45	0.87	2.33
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	5.85	1.35	1.80	2.25
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	9.08	2.03	2.98	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	9.24	1.03	3.59	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	11.29	1.76	3.18	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	6.66	3.33	0.67	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	10.70	1.53	1.02	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	14.14	1.60	1.60	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	8.31	1.32	1.70	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	7.98	0.61	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	11.42	1.63	1.63	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	10.41	2.08	1.46	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	7.57	1.40	1.68	2.52
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	5.15	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	9.29	2.32	0.87	2.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	8.97	0.90	0.60	2.39
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	11.62	4.98	1.11	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	6.72	2.12	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	7.74	1.84	1.84	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	9.21	1.15	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	10.36	1.54	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	8.49	1.13	1.70	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	11.49	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	9.04	2.26	1.81	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	3.59	0.00	2.15	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	6.72	0.75	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	8.92	2.23	1.49	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	6.46	2.58	2.58	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	17.13	1.71	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	8.33	0.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	6.03	1.81	1.21	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	11.38	2.13	1.42	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	12.03	2.41	1.37	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	9.12	2.15	0.54	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	6.73	2.69	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	9.63	1.48	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	11.63	1.16	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	15.87	4.23	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	7.60	1.20	0.40	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	4.36	1.45	0.73	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	6.13	3.07	3.07	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	7.89	0.49	0.49	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	8.47	0.00	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	8.55	2.01	1.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	6.31	2.25	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	1.72	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	7.57	1.34	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	8.21	1.17	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	6.60	0.00	0.66	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	8.30	2.08	2.08	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	9.19	1.31	2.19	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	6.71	1.12	1.12	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	10.60	1.32	1.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	7.71	3.47	1.93	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	6.08	1.01	1.52	2.53
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	11.05	1.44	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	9.54	3.98	0.80	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	7.90	0.61	1.82	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	6.23	4.15	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	10.26	3.04	0.76	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	10.33	0.52	3.10	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	7.86	1.21	2.42	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	13.94	1.27	1.27	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	6.93	2.67	1.60	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	5.17	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	7.71	1.54	1.03	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	6.37	1.41	1.41	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	6.81	0.57	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	11.23	2.08	2.50	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	5.48	0.78	1.57	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	5.85	2.92	1.67	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	9.29	1.86	0.46	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	7.36	2.01	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	8.02	1.60	1.07	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	10.10	2.02	2.02	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	7.34	2.75	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	5.33	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	9.12	3.42	1.71	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	10.74	1.53	1.53	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	7.11	0.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	8.91	1.34	0.89	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	13.78	1.56	2.08	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	5.30	1.33	1.33	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	10.39	6.24	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	24.84	4.10	8.43	2.28
Macrophage - monocyte derived, donor2	11313-117C8	18.90	3.67	5.51	1.28
Macrophage - monocyte derived, donor3	11389-118C3	27.00	2.88	5.37	1.70
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	10.09	2.12	1.06	2.12
Mallassez-derived cells, donor2	11929-125I3	7.92	1.43	1.11	0.32
Mallassez-derived cells, donor3	11930-125I4	8.34	1.39	0.97	0.28
Mammary Epithelial Cell, donor1	11273-116H4	35.17	4.19	5.08	4.88
Mammary Epithelial Cell, donor2	11350-117G9	20.85	4.05	3.19	1.74
Mammary Epithelial Cell, donor3	11422-118F9	13.72	2.24	1.75	0.00
Mast cell - stimulated, donor1	11487-119E2	11.52	0.00	0.68	0.00
Mast cell, donor1	11563-120D6	21.84	2.38	2.49	1.30
Mast cell, donor2	11565-120D8	27.64	2.97	3.57	0.30
Mast cell, donor3	11566-120D9	22.29	5.18	6.30	0.90
Mast cell, donor4	11567-120E1	29.78	4.43	7.09	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	16.63	2.88	3.88	1.33
Mast cell, expanded and stimulated, donor8	11942-126A7	36.19	1.75	3.50	1.17
Mast cell, expanded, donor5	11939-126A4	15.72	3.44	4.82	1.61
Mast cell, expanded, donor8	11941-126A6	23.77	0.84	4.02	1.34
Melanocyte - dark, donor1	11502-119F8	20.60	2.79	1.99	1.49
Melanocyte - dark, donor2	11582-120F7	16.27	1.38	1.38	1.04
Melanocyte - dark, donor3	11663-122F7	16.15	4.49	2.75	0.80
Melanocyte - light, donor1	11274-116H5	5.41	1.18	2.35	0.00
Melanocyte - light, donor2	11351-117H1	7.51	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	7.81	1.73	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	11.35	2.71	1.87	1.15
Melanocyte, donor2 (MC+2)	12739-135I3	13.18	2.15	2.96	1.61
Melanocyte, donor3 (MC+3)	12837-137B2	11.79	2.14	2.68	1.61
Meningeal Cells, donor1	11493-119E8	15.63	3.23	1.36	0.25
Meningeal Cells, donor2	11573-120E7	14.52	3.96	1.32	0.00
Meningeal Cells, donor3	11654-122E7	25.84	3.50	2.69	2.36
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	21.39	4.28	3.99	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	9.36	2.31	1.91	1.41
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2.62	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	19.38	2.87	3.59	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	8.05	1.69	2.33	1.91
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	10.05	0.50	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	7.47	1.54	0.66	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	10.96	0.00	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	8.18	1.02	0.41	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	6.37	4.02	0.97	0.83
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	3.35	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	20.79	3.29	3.82	2.76
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	11.28	0.89	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	12.17	1.92	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	24.81	3.90	1.77	2.48
Mesenchymal stem cells - hepatic, donor0	11218-116B3	21.27	3.75	5.63	1.56
Mesenchymal stem cells - umbilical, donor0	11214-116A8	30.48	5.81	2.18	4.35
Mesothelial Cells, donor1	11247-116E5	5.04	3.71	4.51	1.86
Mesothelial Cells, donor2	12156-128G5	7.01	5.51	1.00	0.00
Mesothelial Cells, donor3	11402-118D7	6.07	2.89	1.59	0.58
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	12.15	4.05	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	22.66	2.22	4.93	1.97
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	12.07	1.47	6.77	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	6.91	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	11.16	3.41	3.41	2.17
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	12.45	2.07	4.56	1.87
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	19.02	3.25	1.75	1.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	12.10	1.40	3.26	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	13.62	3.05	3.86	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	17.82	2.38	5.54	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	14.16	3.54	1.77	7.08
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	17.10	1.90	3.80	2.28
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	9.21	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	14.86	1.70	3.18	2.12
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.97	1.84	2.76	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	11.03	5.07	5.37	2.38
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	1.68	3.35	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	13.30	3.26	1.51	3.01
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	12.60	0.95	1.66	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	8.29	1.11	5.53	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	12.66	2.76	1.15	1.15
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	10.52	0.84	4.00	0.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	11.21	1.63	3.47	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	12.01	2.36	3.00	4.29
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	11.11	2.00	2.45	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	10.29	1.97	2.63	1.31
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	10.65	1.01	1.52	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	9.94	0.00	4.97	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	12.50	1.09	2.72	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	8.53	1.47	3.82	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	7.63	0.00	3.27	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	7.21	1.92	2.40	2.40
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	10.81	1.20	3.20	1.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	6.86	1.37	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	12.51	3.50	0.50	1.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	0.00	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	14.89	0.88	2.63	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	7.73	1.10	1.10	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.04	2.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	8.18	0.99	1.49	1.24
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	7.65	0.70	2.09	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	8.84	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	14.70	1.03	3.08	2.39
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	10.07	1.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	3.91	1.07	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	10.38	1.40	2.52	2.24
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	11.22	1.25	1.66	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	8.16	1.17	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	7.54	1.21	1.21	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	15.03	0.83	2.50	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	14.78	2.77	2.77	2.77
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	14.80	1.71	1.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	10.78	1.24	1.52	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	9.33	3.11	1.55	1.81
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	9.87	0.86	1.72	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	9.53	0.64	1.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	12.28	0.80	1.60	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	14.07	1.50	1.50	1.80
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	9.18	1.13	1.98	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	9.24	0.96	0.32	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	14.82	1.77	1.77	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	15.17	0.00	1.52	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	9.66	1.14	2.56	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	16.47	1.72	1.47	2.21
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	5.21	1.30	1.96	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	15.29	1.47	1.47	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	7.21	2.31	1.44	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	11.95	1.65	7.01	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	11.32	2.38	2.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	0.00	3.77	7.53
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	21.39	1.78	5.35	7.13
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	22.34	0.99	4.93	3.94
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	26.30	2.10	6.31	8.42
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	27.08	2.57	6.33	4.94
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	18.63	0.93	6.52	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	19.90	1.88	5.63	6.01
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	18.11	2.40	5.33	2.13
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	14.48	1.92	3.73	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	18.42	2.95	2.21	2.21
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	21.62	3.30	2.93	4.40
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	28.00	1.56	6.22	4.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	9.09	1.07	1.60	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	24.24	0.00	0.00	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	11.38	2.53	1.69	4.22
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2.72	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	4.45	0.64	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	7.29	0.00	3.24	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	0.00	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	28.55	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	6.52	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	0.00	4.75	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	25.10	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	14.22	4.96	1.72	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	12.54	2.61	1.05	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	9.34	2.00	1.33	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	10.43	1.25	2.50	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	12.36	3.23	2.28	0.95
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	22.34	1.60	3.19	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	8.84	1.36	0.68	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	9.19	0.00	1.84	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	8.79	1.26	1.26	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	20.45	2.79	1.86	1.39
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	11.08	1.08	0.54	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	10.51	2.31	1.26	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	22.27
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	7.45	1.99	1.49	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	6.23	1.62	1.08	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	14.28	2.49	1.59	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	10.45	1.31	1.47	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	5.83	1.82	1.09	1.09
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	7.43	0.53	1.06	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	7.80	2.40	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	1.31	0.98	1.64	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	9.59	1.95	1.30	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	7.41	1.76	0.71	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.14	2.11	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	5.06	2.76	1.84	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	7.39	1.61	2.57	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	4.14	1.03	0.69	2.41
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	5.06	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	7.80	2.23	0.89	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	10.58	1.27	1.27	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	9.26	1.19	2.85	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	8.16	1.72	1.72	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	6.00	1.33	1.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	4.96	0.00	1.35	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	8.73	1.59	1.19	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	11.14	0.93	1.86	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	8.32	2.65	3.41	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	5.54	1.63	1.63	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.10	3.05	1.31	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	5.43	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.94	0.88	1.76	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	7.98	2.66	0.66	1.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	7.44	1.49	0.99	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	8.42	0.77	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	10.28	3.02	3.33	2.42
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	3.76	1.55	0.88	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	11.52	2.03	1.36	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	0.00	5.11	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	7.32	1.83	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	7.24	2.20	2.20	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	8.17	1.21	1.82	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	4.75	1.58	3.16	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	1.13	1.13	1.13	5.67
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	5.06	5.06	5.06
Myoblast, donor1	11241-116D8	14.41	2.11	3.73	1.61
Myoblast, donor2	11322-117D8	19.37	2.49	2.30	1.34
Myoblast, donor3	11398-118D3	19.34	2.86	3.87	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	38.96	1.90	2.48	3.21
Natural Killer Cells, donor1	11230-116C6	20.91	3.69	2.77	1.85
Natural Killer Cells, donor2	11311-117C6	25.03	3.62	2.71	3.02
Natural Killer Cells, donor3	11387-118C1	27.42	4.23	3.13	1.66
Neural stem cells, donor1	11275-116H6	38.11	6.17	5.81	0.73
Neural stem cells, donor2	11352-117H2	44.29	3.85	0.00	0.00
Neurons, donor1	11494-119E9	20.48	3.41	2.28	2.28
Neurons, donor2	11574-120E8	12.33	2.20	1.54	1.10
Neurons, donor3	11655-122E8	23.84	1.64	1.64	3.29
Neutrophils, donor1	11233-116C9	1.86	0.93	1.86	0.00
Neutrophils, donor2	11314-117C9	17.39	0.00	2.90	0.00
Neutrophils, donor3	11390-118C4	8.55	2.44	1.83	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	16.62	4.87	4.16	2.26
Nucleus Pulposus Cell, donor2	11409-118E5	4.88	2.93	0.65	1.63
Nucleus Pulposus Cell, donor3	11462-119B4	10.63	3.21	0.60	1.60
Olfactory epithelial cells, donor1	11933-125I7	10.32	1.79	2.34	3.72
Olfactory epithelial cells, donor2	11934-125I8	17.51	1.74	3.18	3.47
Olfactory epithelial cells, donor3	11935-125I9	12.94	1.70	2.27	2.72
Olfactory epithelial cells, donor4	11936-126A1	21.14	4.19	4.09	3.02
Oligodendrocyte - precursors, donor1	11496-119F2	14.44	5.42	2.41	0.60
Osteoblast - differentiated, donor1	11276-116H7	7.23	3.62	1.28	0.00
Osteoblast - differentiated, donor2	11353-117H3	3.43	1.14	1.14	1.14
Osteoblast - differentiated, donor3	11425-118G3	10.55	4.97	1.86	0.00
Osteoblast, donor1	11277-116H8	14.07	3.32	1.95	0.78
Osteoblast, donor2	11354-117H4	10.53	4.92	4.92	0.70
Osteoblast, donor3	11426-118G4	11.20	4.44	1.60	0.00
Pancreatic stromal cells, donor1	11249-116E7	19.54	4.04	5.98	3.12
Pericytes, donor1	11491-119E6	3.67	1.67	0.22	0.11
Pericytes, donor2	11571-120E5	7.02	2.26	0.91	0.68
Pericytes, donor3	11652-122E5	12.61	4.27	2.44	2.03
Perineurial Cells, donor1	11499-119F5	22.04	5.31	4.18	3.62
Perineurial Cells, donor2	11579-120F4	18.59	2.58	3.31	0.55
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	13.39	0.96	2.87	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	15.92	2.94	3.67	1.96
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	16.95	3.11	3.49	1.04
Placental Epithelial Cells, donor1	11278-116H9	7.17	1.91	2.87	0.96
Placental Epithelial Cells, donor2	11355-117H5	11.09	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	11.39	3.14	1.77	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.54	3.16	0.00	1.58
Preadipocyte - breast, donor1	11467-119B9	7.13	1.50	1.31	1.50
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	22.97	6.00	4.83	2.74
Preadipocyte - breast, donor2	11328-117E5	10.58	3.83	4.50	1.35
Preadipocyte - omental, donor1	11468-119C1	8.42	3.52	1.60	2.66
Preadipocyte - omental, donor2	11329-117E6	10.48	3.49	0.87	0.87
Preadipocyte - omental, donor3	11403-118D8	12.32	5.16	3.01	2.29
Preadipocyte - perirenal, donor1	11469-119C2	10.83	1.97	1.97	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	7.06	2.15	1.54	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	22.84	4.07	4.60	1.77
Preadipocyte - subcutaneous, donor3	11428-118G6	17.88	5.79	4.94	2.21
Preadipocyte - visceral, donor1	11280-116I2	23.38	3.45	4.94	2.61
Preadipocyte - visceral, donor2	11357-117H7	12.42	4.14	2.76	1.38
Preadipocyte - visceral, donor3	11429-118G7	17.76	4.08	2.82	2.72
Prostate Epithelial Cells (polarized), donor1	11253-116F2	54.31	1.36	2.41	3.62
Prostate Epithelial Cells, donor2	11331-117E8	5.15	2.03	0.81	0.27
Prostate Epithelial Cells, donor3	11404-118D9	7.96	1.65	1.35	0.80
Prostate Stromal Cells, donor1	11254-116F3	19.70	3.08	2.62	1.82
Prostate Stromal Cells, donor2	11332-117E9	17.21	1.79	2.69	0.54
Prostate Stromal Cells, donor3	11405-118E1	11.26	3.65	3.65	2.29
Renal Cortical Epithelial Cells, donor1	11516-119H4	7.66	0.36	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	15.25	2.15	3.19	1.59
Renal Epithelial Cells, donor1	11517-119H5	5.07	0.00	2.03	0.00
Renal Epithelial Cells, donor2	11597-120H4	5.69	0.00	0.00	1.42
Renal Epithelial Cells, donor3	11678-122H4	17.36	1.48	3.60	1.27
Renal Glomerular Endothelial Cells, donor1	11514-119H2	6.81	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	15.23	1.75	0.40	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	19.09	1.11	1.55	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	2.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	5.94	0.66	0.88	0.00
Renal Mesangial Cells, donor2	11598-120H5	11.29	2.51	0.63	1.25
Renal Mesangial Cells, donor3	11679-122H5	2.22	0.83	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	11.01	2.15	1.88	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	10.12	1.69	0.42	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	10.99	1.54	1.54	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	25.41	2.59	2.07	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	7.39	1.71	1.42	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	7.20	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	10.54	1.25	0.50	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	101.30	1.74	2.81	7.22
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	16.97	2.68	2.68	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	8.26	1.10	0.55	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	11.02	2.90	1.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	10.27	2.21	0.52	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	13.01	1.89	2.18	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	15.84	1.56	2.45	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	15.13	2.48	1.12	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	15.97	1.75	2.68	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	18.95	1.16	2.77	2.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	11.36	2.88	0.41	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	15.13	1.36	2.12	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	21.32	2.15	2.87	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	11.05	1.72	0.86	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	15.88	1.07	3.33	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	16.82	1.99	1.77	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	12.81	1.15	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	12.58	1.86	2.89	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	19.54	1.50	3.19	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	11.41	1.33	0.40	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	18.98	1.65	3.50	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	19.29	2.10	1.34	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	10.47	2.03	0.53	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	17.66	1.68	1.96	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	14.87	1.03	1.37	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	14.40	1.46	0.18	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	17.66	2.70	1.96	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	18.80	2.28	2.01	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	16.28	2.36	0.47	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	11.71	2.18	2.98	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	19.18	1.17	2.81	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	12.65	2.70	0.21	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	13.05	0.88	1.55	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	16.29	1.25	3.13	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	12.92	2.02	0.40	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	18.73	1.02	1.53	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	17.35	2.51	2.70	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	11.00	1.38	1.03	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	13.44	2.06	2.06	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	16.91	1.48	1.81	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	9.54	1.19	0.51	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	15.09	3.99	3.26	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	17.59	1.87	1.33	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	10.92	1.66	0.69	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	14.05	2.62	2.38	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	16.53	1.01	1.61	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	12.43	1.79	1.04	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	15.72	3.14	2.10	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	13.90	2.72	3.63	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	13.71	2.57	1.10	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	21.69	3.35	5.24	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	20.69	3.04	5.48	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	11.15	1.81	0.90	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	16.51	2.94	3.62	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	20.67	3.29	4.19	3.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	10.98	2.95	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	22.84	2.35	1.49	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	27.04	3.00	4.81	1.20
Schwann Cells, donor1	11498-119F4	6.96	1.50	0.38	0.00
Schwann Cells, donor2	11578-120F3	30.62	6.80	0.00	0.00
Schwann Cells, donor3	11659-122F3	16.21	5.26	1.31	0.88
Sebocyte, donor1	11220-116B5	10.41	2.74	2.19	0.00
Sebocyte, donor2	11301-117B5	6.43	2.30	1.38	0.46
Sebocyte, donor3	11378-118B1	9.48	2.06	2.68	0.21
Sertoli Cells, donor1	11255-116F4	8.28	8.28	3.31	0.00
Sertoli Cells, donor2	11333-117F1	14.12	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	7.74	2.46	1.58	1.76
Skeletal Muscle Cells, donor2	11358-117H8	5.06	0.00	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	16.72	4.18	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	18.85	4.08	1.26	0.79
Skeletal Muscle Cells, donor5	11455-119A6	18.88	3.12	1.04	1.19
Skeletal Muscle Cells, donor6	11459-119B1	26.16	4.46	1.85	2.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	26.97	3.53	4.91	3.78
Skeletal Muscle Satellite Cells, donor2	11321-117D7	23.69	3.71	3.57	1.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	29.17	4.46	2.88	0.89
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	9.18	2.95	1.43	1.77
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	19.54	2.90	0.72	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	9.49	4.13	1.10	0.41
Skin - palm, donor1	10286-104F7	13.43	0.00	2.69	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	5.19	1.30	0.86	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	9.81	4.09	0.82	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	6.75	1.17	0.52	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	9.04	1.67	2.64	1.53
Small Airway Epithelial Cells, donor2	11334-117F2	7.31	1.83	0.84	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	23.26	1.69	3.17	1.69
Small Airway Epithelial Cells, donor3	11406-118E2	8.02	1.20	1.65	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	6.48	5.25	0.62	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	7.34	2.22	0.89	1.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	14.70	5.29	2.94	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	11.93	2.43	1.99	1.10
Smooth Muscle Cells - Aortic, donor2	11360-117I1	9.06	3.54	0.39	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	7.73	0.77	3.09	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	13.01	3.00	4.00	4.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	16.50	3.33	3.19	0.93
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	14.19	5.32	2.88	3.55
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	15.11	4.61	2.18	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	17.26	3.58	3.58	2.93
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	12.11	3.84	2.95	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	22.35	3.70	3.13	1.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	3.25	1.30	0.98	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	14.31	3.96	1.22	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	12.12	6.57	4.29	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	12.24	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	4.77	1.43	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	14.30	3.83	2.95	1.62
Smooth Muscle Cells - Colonic, donor2	11320-117D6	13.13	4.30	1.51	1.29
Smooth Muscle Cells - Colonic, donor3	11396-118D1	20.26	3.36	4.20	1.15
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	10.52	3.25	3.25	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	6.47	2.16	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	8.07	4.48	1.20	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	5.12	0.68	0.34	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	36.28	3.85	4.16	3.61
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	14.59	5.23	2.52	2.21
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	19.57	2.96	2.28	2.96
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	4.83	3.62	0.60	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	28.88	3.71	2.65	2.12
Smooth Muscle Cells - Prostate, donor1	11257-116F6	11.19	3.99	1.46	2.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	13.65	3.26	2.25	1.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	12.68	2.54	2.28	1.01
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	31.36	5.88	3.47	1.36
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	20.25	5.25	4.50	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	9.05	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	6.98	4.19	1.40	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	11.11	2.02	3.53	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	10.34	3.45	0.63	1.88
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	3.83	2.65	0.59	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	42.90	5.58	4.50	0.67
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	20.09	4.67	4.20	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	9.50	2.59	3.31	0.86
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	21.93	2.04	3.06	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	14.67	3.76	0.94	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	23.48	6.15	3.07	1.96
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	26.90	7.29	3.35	2.09
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.86	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	9.05	1.71	1.47	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	7.51	5.30	0.44	2.43
Smooth Muscle Cells - Uterine, donor3	11466-119B8	12.29	2.63	1.76	1.76
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	5.64	2.92	0.97	1.17
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	6.88	4.23	1.32	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	5.21	1.49	1.49	1.86
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	8.26	3.23	1.08	2.87
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	7.67	1.70	0.85	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	9.85	3.15	2.76	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	7.87	2.79	2.79	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	4.39	2.40	3.19	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	6.69	1.25	2.93	3.34
Smooth muscle cells - airway, control, donor4	11969-126D7	6.88	3.21	2.29	2.29
Synoviocyte, donor1	11291-117A4	12.46	3.20	3.70	3.70
Synoviocyte, donor2	11368-117I9	18.77	5.03	4.86	4.86
Synoviocyte, donor3	11440-118H9	8.27	4.92	0.89	2.01
Trabecular Meshwork Cells, donor1	11532-120A2	18.22	2.50	1.07	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	1.98	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	15.51	0.93	1.39	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	14.12	1.29	1.65	1.36
Tracheal Epithelial Cells, donor2	11369-118A1	11.21	3.09	1.93	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	8.59	1.15	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	97.68	3.32	3.57	8.24
Urethra, donor2	10319-105A4	8.99	1.80	1.80	1.80
Urothelial Cells, donor1	11520-119H8	4.52	1.06	0.27	0.00
Urothelial Cells, donor2	11600-120H7	2.00	1.60	1.20	0.00
Urothelial Cells, donor3	11681-122H7	2.75	0.92	0.92	0.00
Urothelial cells, donor0	11216-116B1	11.59	2.45	5.13	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	10.68	0.89	8.01	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	7.15	1.43	4.29	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	13.69	1.37	2.74	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	13.08	5.17	2.75	3.10
Whole blood (ribopure), donor090325, donation2	12177-128I8	12.20	1.74	2.32	2.32
Whole blood (ribopure), donor090612, donation1	12182-129A4	4.16	2.08	5.21	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	8.26	0.92	3.67	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	10.04	0.00	1.83	1.83
Wilms' tumor cell line:G-401	10809-111A8	35.03	2.34	2.34	1.23
Wilms' tumor cell line:HFWT	10597-108E3	14.08	0.88	1.76	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	53.07	5.87	8.10	10.06
achilles tendon, donor2	10292-104G4	12.40	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	25.75	1.27	2.04	4.33
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	27.40	0.70	0.93	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	36.92	2.97	3.44	1.54
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	24.22	6.26	2.72	4.08
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	49.75	1.69	1.41	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	38.07	4.86	4.44	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	25.04	1.36	0.27	3.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	38.34	1.32	0.88	3.08
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	27.36	2.04	3.68	4.90
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	57.08	1.94	3.49	5.44
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	35.88	1.10	1.10	2.39
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	15.60	0.00	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	43.22	1.63	2.79	1.86
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	31.33	2.85	3.11	3.88
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	42.08	1.17	2.92	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	25.10	0.00	2.32	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	31.67	0.82	1.23	2.88
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	23.02	1.23	1.23	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	22.19	2.56	2.56	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	26.99	1.82	2.73	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	25.27	2.41	1.68	2.17
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	20.94	0.67	0.45	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	11.67	0.00	1.67	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	20.44	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	24.86	1.51	0.00	1.88
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	47.54	1.74	1.74	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	13.12	0.00	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	20.02	3.06	4.24	1.41
adipose tissue, adult, pool1	10010-101C1	18.15	4.03	4.81	0.78
adipose, donor1	10184-103D4	31.08	4.10	3.52	6.45
adipose, donor2	10185-103D5	45.42	7.30	3.65	4.46
adipose, donor3	10186-103D6	27.77	3.27	2.45	3.27
adipose, donor4	10187-103D7	25.14	1.73	0.87	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	23.20	5.52	2.05	0.47
adrenal gland, adult, pool1	10081-102A9	10.91	0.00	10.91	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	23.08	1.73	3.34	1.87
alveolar cell carcinoma cell line:SW 1573	10708-109H6	36.44	4.64	2.14	7.86
amniotic membrane cells, donor1	12235-129G3	35.47	9.27	7.42	2.78
amniotic membrane cells, donor2	12236-129G4	27.72	6.76	3.72	1.35
amniotic membrane cells, donor3	12237-129G5	13.55	7.95	2.36	0.29
amygdala - adult, donor10196	10167-103B5	34.39	2.37	1.19	18.97
amygdala, adult, donor10252	10151-102I7	152.48	5.27	5.47	13.18
amygdala, newborn, donor10223	10360-105E9	13.23	1.61	2.26	2.58
anaplastic carcinoma cell line:8305C	10428-106D5	12.73	3.31	1.91	1.53
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	50.08	1.54	1.32	6.18
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	5.01	5.68	0.33	3.67
aorta, adult, pool1	10052-101G7	20.20	5.69	3.73	2.16
appendix, adult	10189-103D9	18.63	6.60	2.33	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	25.11	1.38	5.16	2.06
artery, adult	10190-103E1	13.59	2.72	1.36	4.08
astrocytoma cell line:TM-31	10425-106D2	24.34	2.90	5.79	2.90
b cell line:RPMI1788	10427-106D4	39.11	1.49	2.97	1.34
basal cell carcinoma cell line:TE 354.T	10702-109G9	17.48	6.66	5.83	2.22
bile duct carcinoma cell line:HuCCT1	10432-106D9	22.72	3.57	2.18	1.29
bile duct carcinoma cell line:TFK-1	10496-107C1	5.02	2.18	2.34	1.51
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	27.40	2.80	3.36	5.59
bladder, adult, pool1	10011-101C2	20.97	6.95	4.02	1.85
blood, adult, pool1	10053-101G8	8.86	2.21	0.00	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	5.99	0.86	2.57	0.00
bone marrow, adult	10192-103E3	10.12	1.35	6.75	0.67
brain, adult, donor1	10084-102B3	60.48	4.10	1.03	13.33
brain, adult, pool1	10012-101C3	56.79	5.90	3.67	2.00
brain, fetal, pool1	10085-102B4	24.04	2.67	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	14.87	1.65	1.65	1.32
breast carcinoma cell line:MDA-MB-453	10419-106C5	24.96	1.37	2.12	0.87
breast, adult, donor1	10080-102A8	28.41	2.53	10.73	2.53
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	57.80	2.29	3.43	6.99
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	21.65	1.55	0.93	4.02
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	11.74	2.53	3.68	1.84
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	11.86	1.69	1.45	2.18
carcinoid cell line:NCI-H1770	10703-109H1	7.99	0.94	0.00	4.70
carcinoid cell line:NCI-H727	10735-110B6	12.03	0.77	1.64	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	3.17	0.95	0.32	2.85
carcinosarcoma cell line:JHUCS-1	10642-109A3	11.18	2.66	1.06	2.13
caudate nucleus - adult, donor10196	10177-103C6	29.93	3.45	2.30	6.91
caudate nucleus, adult, donor10252	10164-103B2	161.64	4.52	3.68	6.19
caudate nucleus, adult, donor10258	10379-105H1	51.96	0.76	1.53	12.99
caudate nucleus, newborn, donor10223	10354-105E3	26.37	1.83	0.73	8.06
cerebellum - adult, donor10196	10173-103C2	32.05	2.91	5.83	11.65
cerebellum, adult, donor10252	10166-103B4	48.25	5.98	3.63	2.14
cerebellum, adult, pool1	10083-102B2	21.04	2.41	1.38	5.86
cerebellum, newborn, donor10223	10357-105E6	25.74	0.00	8.30	4.15
cerebral meninges, adult	10188-103D8	43.87	4.03	3.53	4.79
cerebrospinal fluid, donor2	10294-104G6	8.04	1.46	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	10.93	2.88	1.15	1.87
cervical cancer cell line:ME-180	10553-107I4	6.63	2.49	1.49	0.50
cervix, adult, pool1	10013-101C4	16.80	5.67	4.20	1.57
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	14.21	2.09	1.81	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	6.53	1.31	1.31	2.61
choriocarcinoma cell line:BeWo	10423-106C9	20.51	3.11	4.23	1.12
choriocarcinoma cell line:SCH	10785-110H2	18.61	1.85	1.60	3.57
choriocarcinoma cell line:T3M-3	10618-108G6	6.88	1.42	0.24	0.24
chorionic membrane cells, donor1	12238-129G6	19.66	5.70	3.13	0.57
chorionic membrane cells, donor2	12239-129G7	13.82	5.17	2.98	0.40
chorionic membrane cells, donor3	12240-129G8	6.59	3.85	3.30	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	35.34	0.00	1.01	3.03
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	27.85	1.34	2.11	1.54
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	22.17	1.27	2.11	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	14.38	1.28	2.57	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	12.82	0.97	1.21	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	16.90	2.65	2.65	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	22.08	1.77	2.65	1.77
chronic myelogenous leukemia cell line:KU812	10409-106B4	24.24	0.78	4.43	1.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	15.31	2.74	3.89	3.89
clear cell carcinoma cell line:TEN	10636-108I6	16.31	3.30	1.21	2.08
colon carcinoma cell line:CACO-2	10513-107D9	150.83	1.46	6.59	7.32
colon carcinoma cell line:COLO-320	10420-106C6	30.41	2.28	1.52	1.52
colon, adult, donor1	10082-102B1	17.85	4.76	7.14	0.00
colon, adult, pool1	10014-101C5	24.79	6.82	6.93	3.17
colon, fetal, donor1	10070-101I7	22.25	8.65	6.18	3.71
common myeloid progenitor CMP, donor1	12130-128D6	55.00	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	23.80	1.27	1.70	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	26.11	1.81	0.91	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	25.10	1.13	1.27	0.85
corpus callosum, adult, pool1	10042-101F6	63.91	7.85	4.75	5.75
cruciate ligament, donor2	10295-104G7	10.54	0.81	1.62	0.81
diaphragm, fetal, donor1	10069-101I6	11.24	0.80	0.00	0.80
diencephalon, adult	10193-103E4	54.96	6.00	2.16	5.52
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	26.86	0.69	1.38	3.44
ductal cell carcinoma cell line:KLM-1	10438-106E6	13.59	2.82	1.54	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	22.87	2.89	2.17	3.13
ductus deferens, adult	10196-103E7	12.46	2.99	1.99	3.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	30.24	12.96	7.20	8.64
duodenum, fetal, donor1, tech_rep2	10071-101I8	8.09	2.94	3.68	3.68
dura mater, adult, donor1	10041-101F5	18.33	4.71	3.96	1.07
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	23.76	2.44	2.00	1.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	22.07	2.87	2.58	3.15
embryonic pancreas cell line:1B2C6	10604-108F1	8.63	1.85	1.85	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	9.38	0.91	1.82	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	5.87	1.85	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	6.57	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	12.07	1.68	3.02	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	9.61	2.90	1.99	1.09
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	23.48	3.70	1.45	4.50
epidermoid carcinoma cell line:A431	10426-106D3	51.58	3.00	2.56	3.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	19.58	2.64	4.29	1.10
epididymis, adult	10197-103E8	12.35	4.19	5.44	1.67
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	13.48	1.42	1.42	2.13
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	10.22	1.18	1.57	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	21.49	3.54	3.28	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	25.29	3.25	2.46	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	28.57	3.36	4.26	2.02
esophagus, adult, pool1	10015-101C6	22.51	7.22	4.67	1.59
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	9.39	4.88	1.75	0.88
eye - muscle inferior rectus, donor1	10272-104E2	7.24	2.41	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	4.21	4.21	0.00	0.00
eye - muscle medial, donor2	10299-104H2	13.39	1.49	0.00	2.98
eye - muscle superior, donor2	10297-104G9	4.59	2.29	3.44	1.15
eye - vitreous humor, donor1	10268-104D7	8.74	4.37	2.91	0.00
eye, fetal, donor1	10054-101G9	26.44	6.10	3.56	3.81
fibrosarcoma cell line:HT-1080	10758-110E2	18.46	2.05	2.05	1.92
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	15.91	1.42	2.61	0.47
frontal lobe, adult, pool1	10040-101F4	44.75	4.03	2.53	3.75
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	13.81	0.60	3.30	3.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	17.74	2.38	5.58	1.10
gall bladder, adult	10198-103E9	20.76	3.62	4.35	0.97
gamma delta positive T cells, donor1	11937-126A2	24.70	4.29	4.29	2.68
gamma delta positive T cells, donor2	11938-126A3	32.49	2.99	5.23	4.48
gastric adenocarcinoma cell line:MKN1	10614-108G2	17.95	1.90	2.11	2.11
gastric adenocarcinoma cell line:MKN45	10612-108F9	10.25	3.67	4.45	0.58
gastric cancer cell line:AZ521	10549-107H9	30.50	2.46	1.64	1.48
gastric cancer cell line:GSS	10560-108A2	10.98	0.92	10.07	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	17.82	0.91	1.37	1.60
giant cell carcinoma cell line:LU65	10487-107B1	8.72	2.29	2.29	1.49
giant cell carcinoma cell line:Lu99B	10433-106E1	13.86	1.68	2.10	0.84
glassy cell carcinoma cell line:HOKUG	10688-109F4	11.22	1.75	1.50	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	17.31	2.22	1.79	0.84
glioblastoma cell line:A172, tech_rep2	10444-106F3	22.33	3.93	2.53	0.70
glioblastoma cell line:T98G	10485-107A8	21.19	2.10	2.76	0.88
glioma cell line:GI-1	10413-106B8	15.52	1.17	2.05	1.46
globus pallidus - adult, donor10196	10175-103C4	31.34	2.19	2.19	10.20
globus pallidus, adult, donor10252	10161-103A8	92.27	8.54	7.81	6.10
globus pallidus, adult, donor10258	10367-105F7	19.17	4.11	1.37	20.54
globus pallidus, newborn, donor10223	10364-105F4	24.51	2.66	3.73	3.20
granulocyte macrophage progenitor, donor1	12131-128D7	70.97	0.00	7.34	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	41.81	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	6.08	2.56	3.84	0.32
hIPS +CCl2, biol_rep1	14383-156B9	16.07	0.92	0.92	0.46
hIPS +CCl2, biol_rep2	14384-156C1	22.41	1.37	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	24.48	1.93	0.00	1.93
hIPS, biol_rep1	14380-156B6	28.75	1.44	0.00	1.44
hIPS, biol_rep2	14381-156B7	25.38	1.37	0.00	1.37
hIPS, biol_rep3	14382-156B8	24.28	3.31	1.10	5.52
hairy cell leukemia cell line:Mo	10712-109I1	27.30	2.30	2.59	3.74
heart - mitral valve, adult	10205-103F7	17.04	2.09	4.19	2.39
heart - pulmonic valve, adult	10206-103F8	9.94	3.66	2.61	1.57
heart - tricuspid valve, adult	10207-103F9	9.99	2.50	3.33	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	18.77	4.90	3.88	3.26
heart, adult, diseased, donor1	10051-101G6	11.07	8.09	4.68	1.28
heart, adult, pool1	10016-101C7	23.00	8.28	6.21	2.07
heart, fetal, pool1	10046-101G1	11.91	3.08	4.00	0.72
hepatic mesenchymal tumor cell line:LI90	10778-110G4	5.86	2.47	1.54	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	8.32	1.19	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	218.34	2.10	2.76	8.62
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	242.26	1.46	3.16	7.28
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	241.11	2.02	2.63	8.99
hepatoma cell line:Li-7	10484-107A7	17.91	3.34	4.34	2.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	33.06	1.21	1.61	2.61
hippocampus - adult, donor10196	10169-103B7	41.64	2.84	0.95	16.09
hippocampus, adult, donor10252	10153-102I9	181.85	5.71	5.10	10.00
hippocampus, adult, donor10258	10374-105G5	17.93	1.49	0.00	2.99
hippocampus, newborn, donor10223	10363-105F3	22.21	1.41	1.76	3.52
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	34.79	1.83	3.66	6.71
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	34.95	0.98	1.18	3.53
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	34.28	1.78	3.81	3.81
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	55.26	2.82	4.51	3.95
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	53.19	3.36	4.13	8.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	44.79	3.04	3.42	4.56
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	32.11	2.92	2.34	1.75
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	51.49	4.31	1.94	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	46.71	2.09	2.09	2.50
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	27.94	1.66	1.89	1.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	34.88	3.38	1.77	3.70
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	47.13	1.35	2.69	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	32.39	2.50	2.35	4.23
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	23.09	0.98	0.98	4.91
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	34.04	0.87	1.75	6.11
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	53.26	4.77	5.15	4.58
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	46.66	3.92	1.74	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	37.98	4.00	2.50	4.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	52.75	5.84	3.01	4.52
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	54.57	5.46	3.18	3.64
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	36.34	5.01	3.45	7.52
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	16.17	3.27	1.47	4.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	19.16	3.19	1.74	3.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	17.94	2.39	2.09	3.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	38.80	1.29	1.66	5.36
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	36.52	0.57	1.43	3.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	36.75	1.63	4.49	4.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	35.91	3.52	0.70	1.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	44.98	2.22	0.63	2.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	39.64	2.12	2.42	5.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	26.37	2.59	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	37.19	4.65	0.66	3.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	23.60	2.31	0.77	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	18.15	1.79	1.28	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	40.13	1.51	0.76	4.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	23.19	4.37	0.67	3.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	35.26	0.97	1.45	3.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	34.32	0.89	0.89	4.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	42.93	3.41	2.93	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	44.62	2.14	2.14	1.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	58.56	6.51	3.25	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	46.33	2.32	3.31	2.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	39.41	2.19	3.28	2.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	37.27	3.26	1.09	2.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	34.52	3.56	1.78	2.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	23.87	1.19	1.19	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	29.79	3.25	2.44	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	22.09	2.16	1.89	2.16
immature langerhans cells, donor1	11904-125F5	41.16	1.45	2.18	0.73
immature langerhans cells, donor2	11905-125F6	64.16	1.58	6.34	0.79
insula, adult, pool1	10039-101F3	61.80	3.50	1.42	3.41
keratoacanthoma cell line:HKA-1	10791-110H8	19.18	6.83	4.55	3.25
kidney, adult, pool1	10017-101C8	35.75	3.90	4.91	1.80
kidney, fetal, pool1	10045-101F9	21.72	4.53	2.19	0.71
large cell lung carcinoma cell line:IA-LM	10509-107D5	26.27	2.41	2.98	1.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	11.75	3.04	0.83	1.24
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	10.28	1.28	1.28	1.65
left atrium, adult, donor1	10079-102A7	19.07	4.90	3.81	1.63
left ventricle, adult, donor1	10078-102A6	14.16	2.02	5.06	0.51
leiomyoblastoma cell line:G-402	10721-110A1	20.52	1.64	2.46	0.55
leiomyoma cell line:10964C	10569-108B2	10.42	3.59	5.03	1.08
leiomyoma cell line:15242A	10570-108B3	5.43	3.80	0.00	2.17
leiomyoma cell line:15425	10571-108B4	8.26	4.13	3.64	1.21
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	8.36	0.00	2.09	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	17.59	1.42	1.06	0.59
liposarcoma cell line:KMLS-1	10782-110G8	8.59	2.81	1.25	0.94
liposarcoma cell line:SW 872	10726-110A6	13.04	1.10	1.58	0.49
liver, adult, pool1	10018-101C9	136.94	2.92	4.70	2.76
liver, fetal, pool1	10086-102B5	115.71	0.00	1.88	6.58
locus coeruleus - adult, donor10196	10182-103D2	54.68	4.81	2.19	9.19
locus coeruleus, adult, donor10252	10165-103B3	102.79	6.27	3.88	9.41
locus coeruleus, adult, donor10258	10375-105G6	85.49	6.77	3.95	13.26
locus coeruleus, newborn, donor10223	10362-105F2	32.81	1.68	4.63	6.73
lung adenocarcinoma cell line:A549	10499-107C4	10.10	1.38	1.52	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	8.96	3.45	5.52	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	16.48	2.24	3.69	0.40
lung, adult, pool1	10019-101D1	25.63	2.84	5.91	1.06
lung, fetal, donor1	10068-101I5	12.27	5.71	1.71	0.86
lung, right lower lobe, adult, donor1	10075-102A3	31.16	2.75	4.12	4.58
lymph node, adult, donor1	10077-102A5	22.72	1.89	3.31	0.00
lymphangiectasia cell line:DS-1	10727-110A7	24.11	0.66	1.32	1.97
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	31.85	1.36	4.68	3.77
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	17.84	1.70	1.70	1.70
mature adipocyte, donor1	12231-129F8	24.86	4.00	5.33	1.33
mature adipocyte, donor2	12232-129F9	30.30	5.40	7.68	0.83
mature adipocyte, donor3	12233-129G1	22.05	6.87	5.93	0.95
mature adipocyte, donor4	12234-129G2	25.27	4.21	4.74	1.05
maxillary sinus tumor cell line:HSQ-89	10414-106B9	22.63	7.15	6.91	1.43
medial frontal gyrus - adult, donor10196	10170-103B8	21.43	3.38	0.00	14.66
medial frontal gyrus, adult, donor10252	10150-102I6	82.39	3.49	3.86	4.41
medial frontal gyrus, adult, donor10258	10368-105F8	19.70	3.18	1.27	8.90
medial frontal gyrus, newborn, donor10223	10352-105E1	10.24	0.43	1.28	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	56.87	2.87	2.53	6.08
medial temporal gyrus, adult, donor10252	10156-103A3	75.13	4.67	4.46	5.31
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	13.48	1.93	1.93	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00	57.41
medial temporal gyrus, newborn, donor10223	10353-105E2	18.31	1.08	1.44	1.08
medulla oblongata - adult, donor10196	10174-103C3	25.96	6.49	2.60	12.98
medulla oblongata, adult, donor10252	10155-103A2	74.00	6.66	7.59	5.57
medulla oblongata, adult, pool1	10038-101F2	54.77	5.55	2.12	2.12
medulla oblongata, newborn, donor10223	10361-105F1	26.39	2.43	4.51	9.03
medulloblastoma cell line:D283 Med	10838-111E1	28.34	3.10	0.44	0.89
medulloblastoma cell line:ONS-76	10759-110E3	10.52	0.98	1.47	0.24
melanoma cell line:COLO 679	10514-107E1	16.96	2.73	3.31	1.01
melanoma cell line:G-361	10465-106H6	12.76	3.26	2.17	2.17
meningioma cell line:HKBMM	10691-109F7	18.81	2.17	2.89	1.81
merkel cell carcinoma cell line:MKL-1	10843-111E6	15.86	2.64	0.88	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	8.04	1.81	0.52	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	18.72	4.60	1.53	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	10.91	3.45	1.09	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	12.01	2.90	1.66	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	14.05	4.07	1.83	0.98
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	10.21	4.62	0.58	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	13.88	5.55	3.47	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	7.55	2.23	0.86	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	11.62	4.60	1.27	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	10.48	1.72	0.80	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	14.18	2.97	1.22	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	9.82	2.13	1.00	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	6.92	2.63	1.32	1.65
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	9.41	2.91	0.55	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	16.06	2.44	2.79	4.54
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	8.98	3.67	0.82	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	8.63	2.52	0.72	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	7.24	4.55	0.93	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	6.84	1.37	1.82	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	11.33	2.52	0.00	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	8.07	3.59	0.45	0.90
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	8.84	2.89	0.88	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	8.84	3.31	2.58	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	7.15	1.14	2.00	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	10.53	2.53	1.26	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	16.90	4.11	2.28	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	10.23	2.56	2.05	3.07
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	13.09	2.09	2.88	3.14
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	12.63	2.46	0.31	2.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	11.77	3.29	1.18	1.41
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	11.85	2.71	1.69	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	8.25	2.36	0.79	1.96
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	11.58	1.39	0.93	3.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	15.29	4.90	2.60	2.88
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	13.61	4.02	2.01	2.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	11.78	4.57	3.36	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	19.80	5.13	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	11.41	3.02	1.68	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	12.28	3.28	0.41	2.05
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	14.18	0.43	0.43	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	2.73	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	5.16	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	9.74	1.62	1.95	3.25
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	7.27	1.45	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	15.99	2.13	2.67	3.73
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	11.45	1.64	0.00	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	10.88	2.33	1.55	2.72
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	0.00	2.10	4.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	10.93	2.98	1.99	4.97
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	4.77	0.00	9.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	12.45	4.15	1.78	2.96
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	10.97	1.22	4.87	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	10.77	3.17	3.80	4.43
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	13.45	2.76	1.38	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	0.00	0.00	6.45
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	7.98	0.00	7.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	7.74	0.81	2.44	6.52
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	14.30	2.38	0.79	3.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	9.43	0.59	1.18	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	9.35	1.56	0.62	2.81
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	12.03	1.34	1.34	5.35
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	8.28	5.91	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	5.14	2.57	5.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	8.95	2.75	2.75	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	24.74	1.98	2.97	2.97
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	17.94	1.12	3.36	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	16.54	2.54	4.45	9.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	27.00	4.43	2.42	4.43
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	34.89	2.18	2.18	10.90
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	21.54	3.80	6.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	18.21	3.03	0.61	3.03
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	13.56	4.52	13.56
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	28.83	1.65	2.47	8.24
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	18.26	3.37	3.17	4.76
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	10.71	2.27	2.92	3.89
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	11.20	4.07	2.04	6.11
mesodermal tumor cell line:HIRS-BM	10696-109G3	8.51	3.87	1.55	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	8.27	3.78	4.25	2.83
mesothelioma cell line:ACC-MESO-4	10494-107B8	3.48	2.09	1.16	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	0.00	8.55	8.55
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	14.90	1.75	2.67	0.41
mesothelioma cell line:Mero-25	10850-111F4	5.67	1.36	0.91	1.82
mesothelioma cell line:Mero-41	10851-111F5	9.05	2.20	1.71	0.73
mesothelioma cell line:Mero-48a	10852-111F6	9.08	2.88	1.77	1.77
mesothelioma cell line:Mero-82	10853-111F7	16.03	1.05	2.37	1.31
mesothelioma cell line:Mero-83	10854-111F8	9.19	2.21	1.36	1.19
mesothelioma cell line:Mero-84	10855-111F9	11.63	3.54	2.53	3.03
mesothelioma cell line:Mero-95	10856-111G1	13.04	2.69	1.24	1.66
mesothelioma cell line:NCI-H2052	10847-111F1	20.71	3.64	2.65	3.31
mesothelioma cell line:NCI-H226	10846-111E9	12.67	2.53	1.63	1.09
mesothelioma cell line:NCI-H2452	10848-111F2	9.91	1.71	4.44	2.05
mesothelioma cell line:NCI-H28	10845-111E8	10.94	0.51	1.53	1.27
mesothelioma cell line:No36	10857-111G2	15.33	0.98	1.30	0.98
mesothelioma cell line:ONE58	10858-111G3	8.94	1.63	2.98	0.81
migratory langerhans cells, donor1	11901-125F2	8.83	1.92	2.69	0.38
migratory langerhans cells, donor2	11902-125F3	7.94	2.08	1.34	0.73
migratory langerhans cells, donor3	11903-125F4	8.44	1.97	2.69	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	12.08	0.65	0.65	2.29
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	19.50	2.76	1.91	2.54
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	46.99	5.53	4.61	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	17.89	1.71	1.71	1.33
myelodysplastic syndrome cell line:SKM-1	10772-110F7	58.39	2.59	2.59	4.44
myeloma cell line:PCM6	10474-106I6	28.27	1.98	2.97	5.53
myxofibrosarcoma cell line:MFH-ino	10600-108E6	9.64	5.07	1.52	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	16.87	6.47	5.88	1.77
nasal epithelial cells, donor1, tech_rep1	12226-129F3	13.26	2.01	1.00	1.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	7.65	1.84	1.40	0.88
nasal epithelial cells, donor2	12227-129F4	16.56	4.42	3.86	0.55
neuroblastoma cell line:CHP-134	10508-107D4	20.94	0.92	0.92	0.46
neuroblastoma cell line:NB-1	10539-107G8	52.38	3.74	2.81	1.87
neuroblastoma cell line:NBsusSR	10607-108F4	6.54	4.85	1.90	1.05
neuroblastoma cell line:NH-12	10555-107I6	30.93	3.54	0.93	1.30
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	4.51	0.71	0.00	1.90
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	7.60	2.53	1.27	3.96
neuroectodermal tumor cell line:TASK1	10774-110F9	13.08	3.02	2.01	2.21
neuroepithelioma cell line:SK-N-MC	10728-110A8	0.64	1.27	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	8.25	1.06	1.33	1.06
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	72.05	1.69	2.03	2.03
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	19.21	0.80	2.40	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	20.52	3.53	2.24	2.89
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	18.92	3.15	4.20	1.84
nucleus accumbens, adult, pool1	10037-101F1	57.37	4.03	1.69	4.50
occipital cortex - adult, donor10196	10172-103C1	18.54	4.12	2.06	10.30
occipital cortex, adult, donor10252	10163-103B1	80.24	5.10	4.03	6.71
occipital cortex, newborn, donor10223	10355-105E4	11.65	1.46	1.09	0.73
occipital lobe, adult, donor1	10076-102A4	58.25	3.67	2.10	21.25
occipital lobe, fetal, donor1	10073-102A1	11.59	2.15	1.72	4.72
occipital pole, adult, pool1	10036-101E9	28.23	3.71	0.95	0.79
olfactory region, adult	10195-103E6	78.71	4.78	2.10	7.26
optic nerve, donor1	10277-104E7	14.01	4.00	2.00	8.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	12.99	1.59	2.85	1.14
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	58.39	6.73	6.87	4.67
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	12.87	1.69	3.56	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	17.21	2.54	2.31	1.16
osteoclastoma cell line:Hs 706.T	10704-109H2	11.17	2.35	1.76	1.76
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	21.49	5.61	2.80	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	16.33	1.06	1.06	1.06
ovary, adult, pool1	10020-101D2	11.62	4.28	3.32	0.96
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	8.07	1.65	0.73	1.10
pancreas, adult, donor1	10049-101G4	31.04	3.76	5.64	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	7.83	0.28	1.68	2.80
papillary adenocarcinoma cell line:8505C	10437-106E5	9.54	1.87	1.70	3.07
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	13.74	2.48	3.48	1.16
paracentral gyrus, adult, pool1	10035-101E8	38.90	3.48	1.10	2.93
parietal cortex, adult, donor10258	10373-105G4	16.15	5.87	0.73	5.14
parietal lobe - adult, donor10196	10171-103B9	19.75	3.76	0.94	10.35
parietal lobe, adult, donor10252	10157-103A4	54.16	2.28	3.42	2.85
parietal lobe, adult, pool1	10034-101E7	43.53	4.93	2.47	3.00
parietal lobe, fetal, donor1	10072-101I9	18.43	0.97	2.91	2.91
parietal lobe, newborn, donor10223	10356-105E5	18.32	0.75	0.37	2.24
parotid gland, adult	10199-103F1	14.18	3.08	4.32	1.23
penis, adult	10200-103F2	8.59	2.69	4.83	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	5.21	0.56	0.37	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	14.28	1.60	2.33	1.75
pineal gland - adult, donor10196	10179-103C8	10.32	3.23	1.94	1.94
pineal gland, adult, donor10252	10160-103A7	19.54	7.70	3.55	2.37
pineal gland, adult, donor10258	10377-105G8	14.42	5.64	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	8.09	7.08	3.04	6.07
pituitary gland, adult, donor10252	10162-103A9	9.90	5.73	6.25	1.04
pituitary gland, adult, donor10258	10378-105G9	9.36	3.40	5.96	1.70
placenta, adult, pool1	10021-101D3	14.94	4.19	4.95	0.65
plasma cell leukemia cell line:ARH-77	10840-111E3	19.07	1.85	1.72	1.46
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	12.61	1.71	1.56	1.56
pons, adult, pool1	10033-101E6	37.27	7.32	2.50	1.89
postcentral gyrus, adult, pool1	10032-101E5	34.26	3.84	2.01	2.70
promyelocytes/myelocytes PMC, donor1	12132-128D8	54.38	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	0.00	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	17.33	2.04	2.48	1.89
prostate cancer cell line:PC-3	10439-106E7	11.43	1.27	3.45	0.91
prostate, adult, pool1	10022-101D4	22.40	4.44	4.72	2.09
putamen, adult, donor10196	10176-103C5	154.62	2.60	2.36	13.93
putamen, adult, donor10252	10152-102I8	68.63	1.96	3.92	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	13.11	2.19	1.09	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	41.80	3.14	1.93	3.87
putamen, newborn, donor10223	10365-105F5	11.99	2.25	3.75	3.00
rectal cancer cell line:TT1TKB	10469-106I1	6.11	2.04	3.49	0.00
rectum, fetal, donor1	10067-101I4	41.73	4.17	1.39	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	12.72	2.33	3.82	1.48
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	18.64	2.90	8.70	7.87
retina, adult, pool1	10030-101E3	16.80	4.27	4.17	0.89
retinoblastoma cell line:Y79	10475-106I7	62.35	3.64	2.86	2.86
rhabdomyosarcoma cell line:KYM-1	10787-110H4	12.79	1.60	2.46	1.35
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	16.03	3.94	2.25	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	9.85	3.03	1.52	0.76
salivary acinar cells, donor1	11771-123I7	32.86	4.37	1.13	1.78
salivary acinar cells, donor2	11772-123I8	21.89	3.17	2.07	1.10
salivary acinar cells, donor3	11773-123I9	15.89	0.00	1.32	0.66
salivary gland, adult, pool1	10093-102C3	10.87	2.86	1.14	2.86
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	13.32	2.02	2.70	0.59
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	10.81	3.06	1.65	1.53
seminal vesicle, adult	10201-103F3	14.28	3.17	2.65	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	11.17	2.67	3.40	1.94
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	4.78	1.76	1.51	1.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	6.02	2.01	3.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	19.21	1.75	2.01	2.28
signet ring carcinoma cell line:Kato III	10436-106E4	12.82	3.87	2.43	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	13.03	2.32	4.26	1.16
skeletal muscle - soleus muscle, donor1	10282-104F3	6.38	0.00	1.42	0.71
skeletal muscle, adult, pool1	10023-101D5	12.11	4.80	3.48	0.96
skeletal muscle, fetal, donor1	10066-101I3	18.09	7.04	5.03	0.00
skin, adult, donor1	10074-102A2	6.79	6.79	0.00	6.79
skin, fetal, donor1	10065-101I2	17.04	3.79	4.42	6.94
small cell cervical cancer cell line:HCSC-1	10800-110I8	21.68	2.00	1.33	1.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	19.23	1.26	0.95	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	14.84	8.29	2.12	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	16.32	1.81	1.81	1.15
small cell lung carcinoma cell line:NCI-H82	10842-111E5	39.73	1.77	0.64	1.93
small cell lung carcinoma cell line:WA-hT	10562-108A4	18.09	1.31	1.09	0.65
small intestine, adult, pool1	10024-101D6	35.71	6.69	9.20	2.15
small intestine, fetal, donor1	10064-101I1	19.66	4.18	1.97	4.18
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	16.41	0.51	2.05	0.00
smooth muscle, adult, pool1	10048-101G3	17.32	7.75	4.14	1.81
somatostatinoma cell line:QGP-1	10781-110G7	9.11	1.61	1.61	0.00
spinal cord - adult, donor10196	10181-103D1	60.10	3.44	5.28	10.09
spinal cord, adult, donor10252	10159-103A6	41.40	3.94	5.91	5.91
spinal cord, adult, donor10258	10369-105F9	20.75	4.15	2.77	10.38
spinal cord, fetal, donor1	10056-101H2	126.85	6.71	2.44	27.44
spinal cord, newborn, donor10223	10359-105E8	21.58	2.30	5.51	3.67
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	9.56	2.99	2.69	0.60
spleen, adult, pool1	10025-101D7	18.28	2.86	4.41	0.77
spleen, fetal, pool1	10044-101F8	15.33	3.18	2.30	0.40
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	24.43	2.17	4.66	1.35
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	16.52	2.47	1.90	1.14
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	25.16	2.45	4.19	2.10
squamous cell carcinoma cell line:T3M-5	10616-108G4	13.68	1.17	1.95	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	7.32	2.25	1.35	1.69
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	8.47	0.85	3.81	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	20.73	3.38	1.69	0.00
stomach, fetal, donor1	10062-101H8	17.09	6.41	3.20	0.00
submaxillary gland, adult	10202-103F4	22.22	2.85	2.28	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	1411.13
substantia nigra, adult, donor10252	10158-103A5	83.91	8.10	5.82	10.80
substantia nigra, adult, donor10258	10371-105G2	21.72	7.76	1.55	4.14
substantia nigra, newborn, donor10223	10358-105E7	12.01	2.83	3.53	7.07
synovial sarcoma cell line:HS-SY-II	10441-106E9	24.99	9.40	5.50	2.29
temporal lobe, adult, pool1	10031-101E4	46.20	4.07	1.61	3.56
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	9.26	2.85	1.42	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	8.35	0.00	1.32	1.76
tenocyte, donor1	11763-123H8	23.74	2.44	4.89	2.44
tenocyte, donor2	11765-123I1	19.84	6.10	2.67	4.20
tenocyte, donor3	11768-123I4	14.09	7.41	2.59	4.45
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	32.97	2.04	3.57	4.42
teratocarcinoma cell line:NCR-G1	10798-110I6	49.94	2.16	1.70	4.47
teratocarcinoma cell line:PA-1	10807-111A6	59.20	4.96	4.03	4.49
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	66.01	1.14	3.94	6.22
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	34.04	1.13	0.76	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	29.99	1.53	1.20	0.98
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	41.69	0.65	2.28	3.58
testis, adult, pool1	10026-101D8	14.17	5.05	4.62	0.97
testis, adult, pool2	10096-102C6	4.06	2.26	1.35	1.80
thalamus - adult, donor10196	10168-103B6	41.95	9.94	5.52	19.87
thalamus, adult, donor10252	10154-103A1	119.87	4.84	5.94	9.06
thalamus, adult, donor10258, tech_rep1	10370-105G1	23.09	3.08	3.08	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	37.22	4.12	2.80	8.89
thalamus, newborn, donor10223	10366-105F6	22.44	1.73	2.30	7.48
throat, adult	10209-103G2	17.73	3.75	3.00	2.50
throat, fetal, donor1	10061-101H7	17.67	6.09	4.88	4.57
thymic carcinoma cell line:Ty-82	10803-111A2	5.96	2.78	0.40	2.19
thymus, adult, pool1	10027-101D9	16.60	4.37	2.78	0.60
thymus, fetal, pool1	10043-101F7	13.61	1.87	1.77	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	18.22	1.73	1.86	1.86
thyroid carcinoma cell line:TCO-1	10783-110G9	21.79	2.24	1.54	3.77
thyroid, adult, pool1	10028-101E1	32.01	4.85	6.53	2.43
thyroid, fetal, donor1	10060-101H6	18.72	4.48	2.90	5.01
tongue epidermis (fungiform papillae), donor1	10288-104F9	15.40	0.00	0.00	3.08
tongue, adult	10203-103F5	11.16	4.19	2.79	1.40
tongue, fetal, donor1	10059-101H5	18.92	5.52	5.52	4.73
tonsil, adult, pool1	10047-101G2	17.43	3.01	3.81	0.60
trachea, adult, pool1	10029-101E2	19.06	3.76	3.76	0.90
trachea, fetal, donor1	10058-101H4	26.16	5.00	1.92	4.62
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	17.36	1.42	0.71	3.90
transitional-cell carcinoma cell line:5637	10418-106C4	10.23	1.72	0.91	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	34.63	2.51	3.45	1.88
tridermal teratoma cell line:HGRT	10694-109G1	3.81	0.00	1.90	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	28.02	2.54	2.71	2.45
umbilical cord, fetal, donor1	10057-101H3	6.26	8.35	0.00	8.35
uterus, adult, pool1	10100-102D1	7.68	5.12	0.85	0.51
uterus, fetal, donor1	10055-101H1	15.36	3.58	1.54	1.02
vagina, adult	10204-103F6	7.75	3.88	1.29	0.00
vein, adult	10191-103E2	14.03	2.41	3.95	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	13.35	0.53	2.94	0.53